13F Pro Quality Score
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $7.8M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Reported revenue, net income and operating margin by fiscal year, from BIO KEY INTERNATIONAL INC's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $5.9M | $-7.2M | -115.0% |
| FY 2024 | 10-K | $6.9M | $-4.3M | -57.9% |
| FY 2023 | 10-K | $7.8M | $-8.5M | -113.8% |
| FY 2022 | 10-K | $7.0M | $-11.9M | -141.4% |
| FY 2021 | 10-K | $5.1M | $-5.1M | -96.6% |
| FY 2020 | 10-K | $2.8M | $-9.7M | -183.4% |
Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.
BIO KEY INTERNATIONAL INC (BKYI) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. BKYI is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $7.8m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), BIO KEY INTERNATIONAL INC reports quarterly revenue of $1.9M, net income of $-576.9K, an operating margin of -27.6%. Top institutional holders of BKYI by reported 13-F value include GEODE CAPITAL MANAGEMENT, CITIGROUP, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. BKYI trades on the Nasdaq exchange and files with the SEC under CIK 1019034. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BKYI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BIO KEY INTERNATIONAL INC directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 1019034 →